Regional Health Properties, Inc. | 10-Q: FY2025 Q1 Revenue: USD 7.19 M

LB filings
2025.05.15 20:12
portai
I'm PortAI, I can summarize articles.

Revenue: As of FY2025 Q1, the actual value is USD 7.19 M.

EPS: As of FY2025 Q1, the actual value is USD -0.94.

EBIT: As of FY2025 Q1, the actual value is USD -185 K.

Real Estate Services Segment

  • Rental Revenues: $1.548 million for the three months ended March 31, 2025, compared to $1.818 million for the same period in 2024, representing a decrease of 14.9%.
  • Expenses: Facility rent expense was $0.149 million, and depreciation and amortization were $0.324 million for the three months ended March 31, 2025.
  • Loss on Lease Termination: $0.303 million for the three months ended March 31, 2025.
  • Operating Loss: - $249 thousand for the three months ended March 31, 2025.

Healthcare Services Segment

  • Patient Care Revenues: $5.642 million for the three months ended March 31, 2025, compared to $2.309 million for the same period in 2024, representing an increase of 144.3%.
  • Expenses: Patient care expense was $4.401 million, and general and administrative expenses were $1.210 million for the three months ended March 31, 2025.
  • Operating Loss: - $69 thousand for the three months ended March 31, 2025.

Cash Flow

  • Net Cash Provided by Operating Activities: $0.236 million for the three months ended March 31, 2025, compared to $0.597 million for the same period in 2024.
  • Net Cash Used in Investing Activities: - $65 thousand for the three months ended March 31, 2025.
  • Net Cash Used in Financing Activities: - $587 thousand for the three months ended March 31, 2025.

Future Outlook and Strategy

  • Core Business Focus: The company plans to grow operations, streamline cost infrastructure, and increase liquidity through refinancing or repaying debt, increasing lease revenue, modifying lease terms, replacing defaulting tenants, and reducing expenses.
  • Non-Core Business: The company is involved in a merger agreement with SunLink Health Systems, Inc., which includes the issuance of new shares and preferred stock, subject to shareholder and regulatory approvals.